Related by context. All words. (Click for frequent words.) 63 CMV vaccine 62 BioVant 62 HEPLISAV ™ 62 R#/MEM # 61 oral prodrug 61 OncoVEX 61 DPX Survivac 61 OvaRex R 61 PANVAC VF 60 Fodosine 60 therapeutic monoclonal antibody 60 torezolid phosphate 60 oral picoplatin 60 TransVax tm 60 ONCONASE R 60 Phase Ib study 60 TOLAMBA 60 TOCOSOL Paclitaxel 60 successfully commercialize Iluvien 60 Phase 2a clinical trials 60 TOCOSOL Camptothecin 59 HuLuc# 59 Phase #b/#a 59 TransVax ™ 59 Protexia R 59 CRMD# 59 MAGE A3 ASCI 59 apricitabine ATC 59 OvaRex ® MAb 59 DXL# 59 Zemplar Capsules 59 TransVax TM 59 IND submission 59 pafuramidine 59 GALNS 58 candidate REP# 58 PEG SN# 58 Archexin 58 Surfaxin LS 58 Phase 1a clinical 58 Nicotine Conjugate Vaccine 58 Omapro 58 preclinically 58 THR beta agonist 58 DepoVax 58 alvespimycin 58 oral methylnaltrexone 58 forodesine hydrochloride 58 Chimigen TM 58 phase IIa clinical 58 Spiegelmer ® 58 optimal dosing regimens 58 influenza VLP vaccine 58 GRNVAC1 58 tezampanel 58 Inc NVAX 58 Phase III ADT 58 H#N# VLP vaccine 58 NP2 Enkephalin 58 VersaFilm 58 investigational hepatitis B 57 Angiocept 57 TBC# 57 DermaVir Patch 57 UPLYSO 57 SCIB1 57 Memryte 57 Trofex 57 OvaRex 57 Neo Kidney Augment 57 Trofex TM 57 GLP toxicology studies 57 midstage trials 57 obatoclax 57 cannabinor 57 BLA filing 57 Symadex 57 phase Ib 57 CBLC# 57 StaphVAX R 57 tezampanel NGX# 57 next generation URAT1 57 compound INCB# 57 tanespimycin 57 intranasal insulin product 57 Phase IIb clinical trials 57 HQK 57 riociguat 57 Alzhemed TM 57 CINQUIL 57 TRO# 57 Phase IIb trials 57 vosaroxin 57 Harry Palmin President 57 Ketotransdel 57 Phase 2a trial 57 ostarine 56 PSMA ADC 56 PDE4 inhibitor 56 LEP ETU 56 Lisofylline LSF 56 LibiGel ® testosterone gel 56 ALN HTT 56 cathepsin K inhibitor 56 pharmacokinetic PK study 56 stated Michelle Berrey 56 systemic RNAi 56 AFFITOME R 56 zileuton CR 56 PEGylated interferon 56 confirmatory pivotal 56 SynCon 56 cystinosis patients 56 Azedra TM 56 HuMax TAC 56 LE DT 56 HDL Selective Delipidation 56 MAA submission 56 M Enoxaparin 56 dimebon latrepirdine 56 Cytolin 56 Cloretazine R VNP#M 56 Phase IIIb clinical 56 anticoagulant reversing agent 56 subcutaneous PRO 56 forodesine 56 eniluracil 56 Phase #/#a 56 maturation inhibitor 56 Restanza 56 Plicera 56 Neugene 56 im peramivir 56 Phase Ib clinical 56 Inovio DNA 56 MAXY VII 56 ataluren 56 Phase 1a 56 OncoVex 56 samalizumab 55 GED aPC 55 non nucleoside HCV 55 IIa clinical 55 Androxal TM 55 subcutaneous formulation 55 TKM ApoB 55 EGS# 55 SNS# T 55 oral talactoferrin 55 indibulin 55 faropenem medoxomil 55 immatics 55 Alexis Borisy President 55 rxRNA 55 Apoptone 55 immunosuppressant therapies 55 novel therapeutic antibodies 55 Aurexis 55 Exherin TM 55 GRN# 55 Cardio Vascu Grow 55 Bicifadine 55 candidate deforolimus 55 midstage clinical 55 LGLS 55 VLP vaccine 55 Capesaris 55 CCR5 antagonist 55 PNP inhibitor 55 VitiGam TM 55 Dr. Rahul Singhvi 55 Panzem R NCD 55 TLK# 55 phase IIa 55 NEUMUNE 55 Evoltra ® 55 Cloretazine 55 treat dysmenorrhea 55 nalbuphine ER 55 BrachySil TM 55 TMC# [002] 55 preclinical efficacy 55 Synavive 55 Hedgehog antagonist 55 zileuton IV 55 Relovair 55 staphylococcal vaccine 55 EDEMA3 trial 55 Diamyd ® 55 initiate multicenter 55 Phase IIB 55 Phase Ib 55 Howard H. Pien 55 phase IIb clinical 55 phase IIb 55 Fx #A 55 NPC 1C 55 confirmatory Phase III 55 initiated Phase Ib 54 TKM PLK1 54 Menerba 54 small molecule PEGylation 54 deforolimus 54 Phase Ia 54 ProSavin 54 IGF 1R inhibitor 54 TPI ASM8 54 MEND CABG II 54 novel L DOS# 54 ImmunoVEX HSV2 54 Panzem 54 vidofludimus 54 phase IIb study 54 LEX System 54 cobiprostone 54 non nucleoside inhibitor 54 AN# novel 54 systemically administered 54 Phase Ib II 54 torezolid 54 seliciclib CYC# 54 HuMax EGFr 54 CCR2 antagonists 54 MAXY alpha 54 JAK inhibitor 54 HCV protease inhibitors 54 ARIKACE ™ 54 metaglidasen 54 NOX E# 54 #I TM# 54 Isis antisense 54 intranasal insulin 54 Onconase 54 anti CD3 monoclonal 54 relapsed MM 54 novel oral anticoagulant 54 transmucosal delivery system 54 dexanabinol 54 Eniluracil 54 telaprevir VX 54 SMT C# 54 apoptosis inducer 54 Dextofisopam 54 HCV polymerase inhibitor 54 Vaxfectin TM 54 molecular chaperone regulation 54 Tarvacin TM 54 leading oral taxane 54 HepeX B 54 AdhTAP 54 lintuzumab 54 Phase IIA 54 vascular disrupting agent 54 Vaxfectin R 54 Phase IIa trials 54 MVax 54 PREOS R 54 Immunotherapeutic 54 AIMM trial 54 CG# [003] 54 SURFAXIN r 54 oxymorphone ER 54 APEX PD 54 TOCOSOL 54 Q#IR 54 glucokinase activator 54 intranasal formulation 54 CYT# potent vascular disrupting 54 PA# [002] 54 PEG irinotecan 54 volociximab 54 phase IIb III 54 Initiates Phase 2b 54 elotuzumab 54 initiated Phase 1b 54 PROVENGE ® 54 Actilon 54 Neo Kidney Augment ™ 53 TKM Ebola 53 PhG alpha 1 53 NicVAX 53 hepatitis C protease inhibitor 53 ThGRF 53 ALN VSP Phase 53 PI3K/Akt pathway inhibitor 53 Sphingomab TM 53 PROSTVAC VF 53 cancer immunotherapies 53 pivotal bioequivalence 53 TapImmune 53 bardoxolone 53 bavituximab monotherapy trial 53 TNFerade ™ 53 histamine dihydrochloride 53 SUCCEED trial 53 LCP AtorFen 53 Urocidin 53 Phase #b/#a clinical 53 TLR antagonists 53 Curaxin 53 Genvec 53 QTinno TM 53 incyclinide 53 phase IIb trial 53 Inc CRIS 53 Aurora kinase inhibitor 53 EVIZON TM 53 EOquin 53 Troxatyl 53 StemEx 53 oral gallium 53 Prednisporin TM 53 Pyridorin 53 Anturol TM 53 pharmacodynamic PD 53 huC# DM4 53 Phase 1b 53 oral PTH 53 Phase lll 53 Allovectin 7 53 inhibit metastasis 53 EP #R 53 budesonide MMX Phase III 53 ANAVEX #-# [001] 53 ACAPODENE 53 Enhanze Technology 53 paclitaxel poliglumex 53 Prodarsan 53 sapacitabine 53 Hematide ™ 53 Preclinical studies suggest 53 budesonide foam 53 E2F Decoy 53 mg/m2 cohort 53 Jeffrey H. Buchalter 53 Celator 53 ATL# [001] 53 Study #CL# 53 SPRIX ® 53 cangrelor 53 Ragweed Allergy 53 ASONEP 53 Annamycin 53 Maxy G# 53 VIRxSYS 53 Cleviprex TM clevidipine 53 targeting PCSK9 53 Ostabolin C TM 53 Traficet EN 53 Inc. Nasdaq NVAX 53 Trubion Pharma 53 antigen sparing 53 randomized Phase 2b 53 Bioral Amphotericin B 53 BNC# 53 Bellicum 53 squalamine 53 hoFH 53 StemEx R 53 isavuconazole 53 PrevOnco ™ 53 Cytolin R 52 TRACON Pharmaceuticals 52 4SC commented 52 Zenvia ™ 52 SynCon ™ 52 SILENOR ™ 52 MEK inhibitors 52 Acapodene 52 vivo potency 52 XOMA 3AB 52 Diamyd r 52 atacicept 52 Kosan dependence 52 HEPLISAV TM hepatitis B 52 HDAC Inhibitor 52 SinuNase ™ 52 initiate Phase 2b 52 VaxImmune 52 EVIZON TM squalamine lactate 52 pomalidomide 52 tramiprosate Alzhemed TM 52 Actimmune ® 52 SILENOR 52 Pharmacokinetic studies 52 inecalcitol 52 Stimuvax R 52 Diamyd r vaccine 52 Hybridon 52 telomerase activator 52 elacytarabine 52 HCD# [002] 52 generation purine nucleoside 52 Phase IIB clinical 52 personalized immunotherapy 52 rALLy clinical trial 52 molecular imaging radiopharmaceuticals 52 ABSSSI 52 Oxytrex TM 52 DAC HYP 52 Inc. NASDAQ NVAX 52 isoform selective 52 Cand5 52 AVN# [001] 52 Tekmira SNALP technology 52 Cethrin 52 Genz # 52 ACCEDE 52 orally inhaled migraine 52 Charlesson 52 proprietary capillary aerosolization 52 afamelanotide 52 NSABP C 52 RIGScan CR 52 Thorough QT 52 rALLy 52 Transgene therapeutic 52 palifosfamide 52 AKT inhibitor 52 PDE# inhibitors 52 Tarvacin Anti Cancer 52 initiate Phase IIb 52 Solorel ® 52 registrational 52 treats acute lymphoblastic 52 intradermal injections 52 Phase #b/#a trial 52 TetraLogic 52 Tolerx 52 HIV maturation inhibition 52 theranostic 52 dose escalation phase 52 PRESEPT 52 SEPET TM 52 Chemophase 52 Pafuramidine 52 confirmatory clinical 52 Mipomersen 52 oncolytic viruses 52 Phase 1b clinical trials 52 Nicole Onetto MD 52 Selzentry maraviroc 52 lorvotuzumab mertansine 52 evaluating picoplatin 52 TRIOLEX HE# APOPTONE HE# 52 Initiate Phase II 52 vaginally administered lidocaine 52 AERAS 52 eritoran 52 registrational trial 52 semi synthetic lipoglycopeptide 52 Juvaris 52 evaluating satraplatin 52 IND enabling 52 Fc engineered 52 Stapled Peptide 52 novel RNAi therapeutics 52 ritonavir boosted danoprevir 52 Synavive ™ 52 BHT DNA 52 Advaxis Phase 52 dacetuzumab 52 Christian Itin Ph.D. 52 Prolor 52 OXi# 52 Prosaptide 52 Oral NKTR 52 epigenetic therapies 52 Phase 1b clinical 52 octreotide implant 52 OMP #R# 52 FM VP4 52 Ceflatonin 52 Troxatyl TM 51 DCCR 51 MEND CABG 51 antiangiogenic agents 51 Clay B. Siegall 51 tropism testing 51 Litx 51 elvucitabine 51 TRX1 51 DACH platinum 51 adrenergic regulation 51 Insulin PH# 51 Dr. Avtar Dhillon 51 resminostat 51 TG# [003] 51 Juvaris BioTherapeutics 51 generation PNP inhibitor 51 PREGNANT Study 51 RPL# 51 antigen rPA anthrax 51 celgosivir 51 torsemide ER 51 ImmunoCellular Therapeutics 51 faropenem 51 OraTest R 51 selective kinase inhibitors 51 NYSE Amex CVM 51 therapeutic monoclonal antibodies 51 MethyPatch 51 CPL Biologicals 51 MET amplification 51 pharmacodynamics PD 51 recombinant PSMA vaccine 51 TACI Ig 51 Nektar proprietary 51 Linjeta TM 51 LibiGel ® Phase III 51 MET inhibitor 51 rindopepimut 51 Behcet uveitis 51 ABthrax TM raxibacumab 51 NEBIDO 51 BST CarGel R 51 Oncotype DX colon cancer 51 Thorough QT Study 51 Solazed 51 Omthera 51 Bendavia 51 Amplimexon 51 MAP# 51 LymphoStat B TM 51 BiDil XR 51 efficacy tolerability 51 Exelixis compounds 51 pharmacokinetic characteristics 51 APEX AMI 51 ACCLAIM II 51 PD2i CA Cardiac Analyzer 51 REGEN trial 51 immunotherapeutic approaches 51 EVIZON ™ 51 OLpur TM H2H 51 VEGF inhibitor 51 edifoligide E2F Decoy 51 advanced carcinoid 51 romidepsin novel 51 E1 INT TM 51 Anticalin 51 Veronate 51 rhIGF-I/rhIGFBP-3 51 Cardioxyl 51 synthetic siRNA 51 Plenaxis TM 51 PF # [002] 51 IAP inhibitor 51 VITAL Trial 51 Aganocide ® 51 SURFAXIN 51 Toremifene 51 Prestara 51 PRESEPT study 51 vivo toxicology 51 INS# [002] 51 thorough QT 51 Bioaccelerate compounds under 51 QNEXA 51 Urocortin 2 51 Vaccinex 51 NASDAQ PGNX 51 ALSYMPCA 51 Muraglitazar 51 NASDAQ CLDX 51 Phase III psoriasis 51 product TNFerade TM 51 macitentan 51 Cerebril TM 51 methylnaltrexone 51 Epanova 51 skeletal sarcomere activator 51 edifoligide 51 LHRH antagonist 51 granted Ortec 51 Dr. Marlies Sproll 51 blinded randomized placebo controlled 51 Elusys 51 Fentanyl TAIFUN R 50 neuroprotective properties 50 SAR# [004] 50 anti infective therapeutics 50 Rahul Singhvi 50 Cogane 50 Nasdaq MITI 50 receptor tyrosine kinase inhibitor 50 cGMP manufacture 50 ABSORB clinical 50 oral interferon 50 Vion Pharmaceuticals 50 polymer conjugate technology 50 X Excite 50 AFREZZA ® 50 RSD# oral 50 Chimigen 50 Fibrillex TM 50 fosbretabulin 50 lintuzumab SGN 50 RiVax ™ 50 Phase III TRIST 50 using VIAdel TM 50 monoclonal antibody therapeutics 50 PFO migraine 50 HCV nucleoside polymerase inhibitors 50 omacetaxine mepesuccinate 50 Empatic 50 Aurora kinase inhibitors 50 Pagoclone 50 KRYSTEXXA TM pegloticase 50 ticagrelor Brilinta 50 monoclonal antibody therapies 50 HCV polymerase 50 novel antiviral therapeutics 50 inhaled liposomal ciprofloxacin 50 DDP# 50 canagliflozin 50 Tarceva TM 50 ISTODAX 50 mTOR inhibition 50 PCK# 50 clinical pharmacology studies 50 tramiprosate ALZHEMED TM 50 Pertuzumab 50 iii GTx 50 Benlysta belimumab 50 dirucotide 50 MGd 50 vaginal lidocaine 50 ADAGIO study 50 BioNumerik 50 VentiRx 50 sNDA submission 50 fibrotic disease 50 Inc. Nasdaq INFI 50 CELVAPAN H#N# 50 NNR Therapeutics 50 Technosphere Insulin System 50 chemopreventive agent 50 PORxin TM 50 balsalazide tablet 50 Ceplene TM 50 AZX# 50 RESTORE CLI trial 50 LibiGel testosterone gel 50 talactoferrin 50 AMPK activators 50 phase Ib clinical 50 NEUGENE antisense 50 punctal plug 50 ARISE Phase III 50 POSIDUR TM 50 PDE# 50 Nasdaq PGNX today 50 Addrenex 50 Cleveland BioLabs 50 Steven A. Kriegsman 50 Epiphany Biosciences 50 pharmacological chaperone 50 AVRX 50 Amoxicillin PULSYS Phase III 50 endothelin antagonist 50 iroxanadine 50 Neotropix 50 Nanobodies ® 50 VP# [004] 50 PEP# [003] 50 PsychoGenics 50 randomized Phase IIb 50 Idenix Pharma 50 PRECISE trial 50 GlycoMimetics 50 Protalex Inc. 50 Nasulin 50 Inc. NASDAQ GNVC 50 UVIDEM 50 sirtuin therapeutics 50 DiLA2 liposomes 50 Adenosine Therapeutics 50 Bionutrics 50 IMC A# 50 varespladib 50 isatoribine 50 QLT Plug Delivery 50 Canvaxin TM 50 Aegerion Pharmaceuticals 50 EECP ® therapy 50 Phase 2a preventative 50 canakinumab 50 Phase IIb III 50 DURIN TM 50 GCP compliant 49 Telintra 49 preclinical pharmacokinetic 49 3 registrational trial 49 William J. Gastle 49 Phase III HEAT 49 PEGPH# 49 Iomai Corporation 49 preclinical 49 Kahalalide F 49 MERLIN TIMI 49 Posiphen 49 Luveniq 49 IMPACT IMmunotherapy 49 RNAi therapeutic targeting PCSK9 49 bardoxolone methyl 49 multicenter Phase II 49 EVIZON 49 commercialize CorMedix drug 49 topical antifungal product 49 NDA resubmission 49 Nasdaq ACHN 49 KaloBios 49 OMAPRO 49 oral opioid modulator 49 ReN# 49 SYMMETRY trial 49 Nasdaq INHX 49 unique alkylating agent 49 Nasdaq VRTX 49 GLP1 agonist 49 Virulizin R 49 NYSE Amex PTN 49 rPA vaccine candidate 49 PRIMO CABG 49 EMPOWER ™ 49 BRIM3 49 product AMD# 49 NASDAQ BCRX 49 EmbraceAC 49 Urocidin TM 49 class mGluR5 inhibitor 49 my3KG 49 Inovio Pharmaceuticals 49 NYSE Amex HEB 49 iSONEP 49 sitaxsentan 49 EMPOWER TM 49 Nasdaq AGEN 49 fusion enhancers 49 UltiMAb R technology 49 Hematide ™ peginesatide 49 AMEX AIS 49 KIACTA ™ 49 Endoscopic Ablation System 49 Chemokine Therapeutics 49 pandemic influenza vaccine 49 TRIOLEX TM HE# 49 BLyS specific 49 brentuximab vedotin SGN 49 Dr. Bahcall 49 ponatinib 49 Cintredekin besudotox 49 Cylene 49 Tß4 49 BN# [002] 49 intradermal injection 49 ENRICH trial 49 file INDs 49 ALISTA 49 NASDAQ NVAX 49 Lupuzor 49 tolerability pharmacokinetics 49 PRNewswire FirstCall Novavax 49 NASDAQ INFI 49 HIV integrase inhibitors 49 Mr. Rosconi 49 drug GLPG# 49 opioid bowel dysfunction 49 SEASONIQUE 49 PMA submission 49 AMEVIVE 49 LEAPS H#N# 49 Mycophenolate mofetil 49 RAPTIVA 49 Phase 2b clinical trials 49 GLPG# 49 pharmacodynamic markers 49 ZYBRESTAT fosbretabulin 49 NASDAQ AVEO 49 Aptocine 49 skeletal sarcomere activators 49 Oncogenex 49 predictive toxicology 49 CCR1 49 NS5A 49 BEZ# 49 Dacogen injection 49 Fibrostat R 49 oral rivaroxaban 49 Scopus Affiliation Identifier 49 Genocea Biosciences 49 MBRX 49 PolyTouch 49 Oxigene 49 Peregrine Pharma 49 aurora kinase inhibitor 49 EnzymeRx 49 Tovaxin ® 49 Hsp# inhibition 49 DEEP AF 49 Versartis 49 exploratory Phase IIa 49 aEURoeThis 49 IIb clinical trial 49 Nventa 49 Scancell 49 Cempra 49 GTHP 49 recurrent glioblastoma multiforme 49 familial hypercholesterolemia FH 49 Maraganore 49 commercialize DAVANAT ® 49 brivaracetam 49 Pancreate 49 SCOLR Pharma 49 protein kinase inhibitors 49 Michael Fonstein Ph.D. 49 advanced compound INCB# 49 AERx iDMS 49 GSK# [001] 49 Excellagen 49 Tyzeka Sebivo 49 pipeline GlycoPEG GCSF 49 LB# [003] 48 romidepsin 48 Expression Genetics 48 Galenea 48 Opexa 48 immunostimulatory effects 48 dendritic cell vaccine 48 sterile lidocaine patch 48 NASDAQ NABI 48 FoldRx Pharmaceuticals Inc. 48 Shire BioChem Inc. 48 Loretta M. Itri 48 bevasiranib 48 Cloretazine R 48 OTCBB DORB 48 recurrent herpes labialis 48 rotary VAD 48 anti amnesic 48 Nasdaq MAXY 48 oral ghrelin agonist 48 Dr. Boro Dropulic 48 BEXXAR 48 InNexus Biotechnology 48 IL-#/# 48 NASDAQ VICL 48 Rylomine TM 48 orally administered inhibitor 48 potentially treat nephropathic 48 potent suppressor 48 anticancer therapeutics 48 ACHN 48 dosing cohort 48 ON #.Na 48 NOVAVAX 48 Protox 48 FavId 48 QNEXA ® 48 initiate Phase Ib 48 Xcellerex FlexFactory 48 visilizumab 48 CCR5 inhibitor 48 Azaya 48 Bevasiranib 48 VaxInnate 48 ICA # 48 Gemin X 48 alemtuzumab MS 48 unblinding 48 cilengitide 48 candidate brentuximab vedotin 48 Urokinase 48 BLOOM Behavioral modification 48 PD2i Analyzer 48 estrogen receptor modulators 48 ACOMPLIA R 48 Lucanix R 48 Remi Barbier 48 NASDAQ DVAX 48 Harbor BioSciences 48 Myoblast Program 48 alkylating agent 48 Alequel ™ 48 Zoraxel TM 48 basal insulin analogue 48 NASDAQ ARRY 48 Novavax 48 LigoCyte 48 signal transduction inhibitor 48 Phase III Clinical Trials 48 novel anticancer 48 Nanobodies 48 Specifid 48 MDS AML 48 Btk inhibitor 48 AlphaVax 48 PROMACTA 48 Arginox 48 oxidative stress inducer 48 PD2i ® algorithm 48 PharmaNova 48 Nasdaq IMGN 48 Nasdaq HALO 48 anti infective medicines 48 teplizumab 48 Anadys 48 Targretin capsules 48 SonoLysis 48 Aeolus Pharmaceuticals 48 motesanib 48 EDEMA3 48 clinicaltrials 48 relapsed MCL 48 novel chimeric natriuretic 48 HCV antiviral 48 Ohr Pharmaceutical 48 Technosphere R 48 drugable targets 48 posaconazole 48 CYT# vascular disrupting 48 ATIR ™ 48 JAK3 48 regenerative medicine therapies 48 Tekmira lipid nanoparticle 48 QLT# 48 Mesafem 48 maturation inhibition 48 NADiA ProsVue 48 NASDAQ IMGN 48 tosedostat 48 Transave 48 Fibrocell Science 48 Alnara 48 hematological indications 48 angiotensin analog 48 Posiphen TM 48 Cerimon 48 Pfizer maraviroc 48 solanezumab 48 Intraject 48 apricitabine 48 Vascular Wrap TM 48 delay bone metastases 48 Agile Therapeutics 48 ImmuneY2 48 Oral lyn 48 daclizumab 48 Molecular Insight 47 Addrenex Pharmaceuticals 47 ghrelin antagonist 47 Syndax 47 blockers angiogenesis inhibitors 47 ZFP technology 47 Pepducin 47 Garcia Manero 47 Novavax VLP 47 MVA MUC1 IL2 47 REMOXY ® 47 evaluating Actimmune 47 Antigen Express 47 Ceflatonin R 47 autoimmune cardiovascular 47 dose cohort 47 pain palliation 47 complete cytogenetic response 47 OncoVAX ® 47 epigenetic therapeutics 47 Albuferon Phase 47 Phase IIa clinical trials 47 initiate Phase IIa 47 ALTU 47 pharmacokinetic pharmacodynamic 47 Portola Pharmaceuticals 47 Onno van de Stolpe 47 Somatuline Autogel 47 huN# DM1 47 FermaVir 47 Cerovive 47 CHAMPION PCI 47 REVIVE Diabetes 47 ALB # 47 ThromboGenics commented 47 atherosclerosis regression 47 TransMID 47 microRNA biomarkers 47 CeNeRx BioPharma 47 developing ViaCyte SM 47 MacuSight 47 severe oral mucositis 47 anticancer activity 47 patented DepoVax ™ 47 patented DepoVax TM 47 Nasdaq IDIX 47 antituberculosis 47 IND Investigational New 47 experimental hepatitis C